SEC Form D private-offering filing

ELIXIRGEN THERAPEUTICS, INC.

Name: ELIXIRGEN THERAPEUTICS, INC. - new SEC Form D private-offering filing, Baltimore, MD
Published: 2025-11-13

A new SEC Form D private-offering notice from Baltimore, MD, a $4,000,000 filer-stated offering target in Biotech. The source filing is one click away.

ELIXIRGEN THERAPEUTICS, INC. site↗ Verified via SEC Form D

Clinical stage biotech developing gene therapies for rare and aging associated diseases, including a telomere elongation therapy and an mRNA delivery platform for large genetic payloads.

Filed 2025-11-13Filed to raise $4,000,000First money in 2025-10-30Raised so far $4,000,000HQ (as filed) Baltimore, MDSector Biotech ✓Stage (inferred) SeedCall status Call-ready

Source linked the Form D on EDGAR↗Website verified elixirgentx.com↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in Maryland →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.